TargetTab™ utilizes wireless power supply with no onboard battery and proprietary innovative smart polymer technology for the actuation and release system.
The SmartTab® platform connects with a smartphone or smartwatch via bluetooth RF signal to monitor for statistical based therapy optimization.
Targeted delivery to the stomach, intestines and colon. Potential to treat local diseases such as Crohn’s disease, inflammation, and ulcerative colitis.
Providing a patient-friendly oral route of administration and the ability to confirm drug delivery can improve patient outcomes and compliance.
The capsule’s selective drug release reduces the required dosage and the side effects that these drugs often produce through exposure to non-targeted areas.
Ushering in a new pharmaceutical era in which drug delivery data is monitored in real-time, personalized and integrated with health information systems.
InjectTab™ is an oral drug delivery system for biologics and large molecules. A revolutionary micro-needle capsule that confirms self-orientation and ideal positioning to deliver biologics via injection into the stomach wall.
TargetTab™ is an oral drug delivery system that can determine the capsule’s location in the gastrointestinal tract and trigger the release of drug therapy at a predetermined location for IBD and other GI related diseases.
SmartTab® recently published “Advancing High Tech Drug Delivery Systems for the Treatment of Crohn’s Disease” in Inflammatory Bowel Diseases (IBD) Journal, and the Journal of Gastroenterology. A poster of distinction, as one of the top-scoring abstracts at the Crohn's and Colitis Congress 2021.
